These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 483047)

  • 1. [Hazards in the application of biological products].
    Fernández de Castro J
    Salud Publica Mex; 1978; 20(5):539-57. PubMed ID: 483047
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative toxicity of compounds used as preservatives in vaccines and biologics.
    Geier DA; Jordan SK; Geier MR
    Med Sci Monit; 2010 May; 16(5):SR21-7. PubMed ID: 20424565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination of patients with allergy].
    Halvorsen R; Pettersen M
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):396; author reply 396. PubMed ID: 14963530
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccines, cells and nucleic acids].
    Zuckerman AJ; Deinhardt F
    Bull World Health Organ; 1990; 68(3):293-5. PubMed ID: 2393975
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccinations--allergies].
    Hrynczuk J
    Ugeskr Laeger; 1995 Jun; 157(25):3636-7. PubMed ID: 7652986
    [No Abstract]   [Full Text] [Related]  

  • 6. An algorithm for treatment of patients with hypersensitivity reactions after vaccines.
    Wood RA; Berger M; Dreskin SC; Setse R; Engler RJ; Dekker CL; Halsey NA;
    Pediatrics; 2008 Sep; 122(3):e771-7. PubMed ID: 18762513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introductory remarks: viral safety of biologicals.
    Horaud F
    Dev Biol Stand; 1991; 75():3-7. PubMed ID: 1794630
    [No Abstract]   [Full Text] [Related]  

  • 8. The complex link between immunization against childhood diseases and allergy.
    Kalaboka S; Annesi-Maesano I
    Expert Rev Vaccines; 2007 Aug; 6(4):635-43. PubMed ID: 17669015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allergic reactions and vaccines: distinguishing true and false reactions].
    Caubet JC; Siegrist CA; Eigenmann PA
    Rev Med Suisse; 2009 Feb; 5(191):416-9. PubMed ID: 19331098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General recommendations on immunization.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Apr; 38(13):205-14, 219-27. PubMed ID: 2927385
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic reactions to vaccines.
    Alves RR; Gaspar A; Ferreira MB
    Eur Ann Allergy Clin Immunol; 2007 Oct; 39(8):269-77. PubMed ID: 18237005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of ulcer patients with a 30 percent alcohol solution of propolis].
    Gorbatenko AG
    Vrach Delo; 1971 Jan; (1):22-4. PubMed ID: 5576574
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral safety of biological products in WHO policy.
    Grachev VP
    Dev Biol Stand; 1991; 75():241-6. PubMed ID: 1794628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Knowledge of selected occupational groups about biological agents in the environment and ways of health protection against occupational exposure to biological hazards].
    Zielińska-Jankiewicz K; Kozajda A
    Med Pr; 2003; 54(5):399-406. PubMed ID: 14978888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologicals: an attempt at classification and its implication for the viral safety of products.
    Horaud F
    Dev Biol Stand; 1993; 81():17-24. PubMed ID: 8174800
    [No Abstract]   [Full Text] [Related]  

  • 16. Do vaccines modify the prevalence of asthma and allergies?
    Sánchez-Solis M; García-Marcos L
    Expert Rev Vaccines; 2006 Oct; 5(5):631-40. PubMed ID: 17181437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological agents? A new professional risk].
    Trabacchi G
    Rev Infirm; 1996 Oct; (15-16):52-7. PubMed ID: 9001056
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse side-effects to biological agents.
    Pichler WJ
    Allergy; 2006 Aug; 61(8):912-20. PubMed ID: 16867042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment related to veterinary biologicals: side-effects in target animals.
    Martinod S
    Rev Sci Tech; 1995 Dec; 14(4):979-89. PubMed ID: 8639966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities.
    DiMartino LD; Curtis LH; Williams RL; Abernethy DR; Schulman KA
    Food Drug Law J; 2008; 63(4):891-900. PubMed ID: 19601387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.